MAZE
Maze Therapeutics, Inc. · Healthcare
Chief Executive Officer Jason Coloma V sold $922K of Maze Therapeutics, Inc.
Sold$922,315
$26.73Price
34,501Shares
−12%Stake
What MAZE did after the filing
- The stock from Thu, Aug 6 open, $27.89
- −19.7%
- S&P 500, same days
- +0.4%
Measured over 30 trading days, to the Sep 21 close.
Traded Mon, Aug 3. Filed Wed, Aug 5, 4:08 PM ET, after the close. Returns use the Aug 6 open and the Sep 21 close. Not investment advice.